Form 4: Pfizer SVP & Controller Jennifer B. Damico Reports Acquisition of Phantom Stock Units

Jennifer B. Damico, SVP & Controller of Pfizer Inc., reports the acquisition of 108 phantom stock units through the Pfizer Supplemental Savings Plan.

Summary

• On April 10, 2024, Jennifer B. Damico, SVP & Controller of Pfizer Inc., acquired 108 phantom stock units.
• The acquisition was made through the Pfizer Supplemental Savings Plan (SSP).
• Each unit represents one phantom share of Pfizer common stock.
• The price of the derivative security is $26.32.
• Following the transaction, Damico directly owns 27,806 derivative securities.
• These units are settled in cash following separation from service and can be transferred into an alternative investment account at any time.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects routine insider activity, suggesting confidence in the company's future, but it's not a major event.

Positives

• The acquisition of phantom stock units aligns the executive's interests with the company's performance.
• The Pfizer Supplemental Savings Plan provides a mechanism for executives to accumulate wealth tied to the company's stock.

Future Outlook

The document does not contain any specific forward-looking statements regarding Pfizer's future performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates an executive's continued investment in the company's stock, which is generally viewed positively.

Stakeholder Impact

• The acquisition of phantom stock units by a company executive can be viewed positively by shareholders as it aligns management's interests with the company's performance.

Key Dates